Nebraska bill would expand insurance coverage for Alzheimer’s tests and treatments

LINCOLN, Neb. (KLKN) — A new bill in the Nebraska Legislature could expand access to testing and treatment for people living with Alzheimer’s disease and related dementia.

State Sen. Jason Prokop introduced the measure, which would require insurance companies to cover certain Food and Drug Administration-approved tests and treatments for Alzheimer’s disease.

Currently, Nebraskans are not guaranteed coverage and often must try less-expensive treatments before gaining access to newer drugs.

Supporters say the proposal would remove financial barriers that can delay care and limit treatment options.

“These treatments allow those living with Alzheimer’s disease to stay independent longer, to stay at home longer,” Alex DeGarmo, state government relations director for the Alzheimer’s Association of Nebraska, said.

Advocates say early diagnosis is critical, giving patients and families more time to prepare for the progression of the disease and to make important medical and financial decisions.

“When families receive a diagnosis of Alzheimer’s disease, it can be a very difficult time for them,” DeGarmo said. “We want to ensure that when they go through this, they have access to treatment — affordable treatment — and make sure their insurance coverage will be there for them.”

The Alzheimer’s Association says many families struggle to cover the cost of testing and treatment because insurance does not consistently cover them.

That lack of coverage can force patients to delay care or forgo newer therapies altogether.

Supporters of the bill say the measure would help ensure families have access to what they describe as life-altering treatments.

“I understand that it’s a very difficult time, and these treatments can be very expensive,” DeGarmo said. “You are the reason why we are bringing this. We want to make sure people have access to these life-altering treatments.”